For any biopharmaceutical company, the regulatory reporting clock starts once any member of the organization becomes aware of a safety event. Typically, adverse reaction data is collected from a number of different places including affiliates, call centers, co-licensing partners, consumers, healthcare providers, CROs, literature, etc. This data is collected in a variety of formats – both structured and unstructured.
agXchange Inbound Receipt and Tracking (IRT) enables global collection of this data securely and efficiently. Using agXchange IRT , companies can harmonize their safety data receipt, assessment and tracking processes across all safety offices globally using one system, leading to improved compliance and efficiency gains.
As with all Aris Global products, agXchange IRT is available on premise or on demand (SaaS).
Using agXchange IRT, gives teams at processing centers the opportunity to triage an inbound safety report prior to promoting it to the central pharmacovigilance database. They can check these reports against existing cases in the safety database to ensure duplicate cases are removed from the processing workflow and initial and follow-up reports are assessed appropriately.
When implemented with ARISg, agXchange IRT enables a seamless safety case receipt and processing workflow and facilitates tracking and reconciliation of all pharmacovigilance data through the stages of receipt, processing at regional centers and headquarters, and outbound submissions to authorities and partners from local offices.
agXchange IRT offers several other key features including:
agXchange IRT takes advantage of the inherent productivity benefits of electronic communication, serving to decrease the amount of time organizations spend collecting and verifying pharmacovigilance information. It also enhances the ability to monitor and execute on global compliance requirements.
Specific agXchange IRT benefits include: